News and resources
Medical journals and reports
The following publications and resources provide insight and information about over-the-counter (OTC) oral contraception.
Women’s health reports
- Grindlay K, Key K, Zuniga C, et al. Interest in continued use after participation in a study of over-the-counter progestin-only pills in the United States. Womens Health Rep (New Rochelle). 2022;3(1):904-914.
Contraception journal
- Glasier A, Edelman A, Creinin MD, et al. The effect of deliberate non-adherence to a norgesterol progestin-only pill: a randomized, crossover study.
- Glaiser A, et al. A review of the effectiveness of a progestogen-only pill containing norgestrel 75 μg/day. Contraception. 2022;105:1-6.
- Glaiser A, et al. Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity. Contraception. 2022;112:37-42.
- Han L, et al. Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception. Contraception. 2022;112:43-47.
- Guillard H, et al. Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S. Contraception. 2023;117:7-12.
- Steiner RJ and McDonald-Mosley R. Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access. Contraception. 2023. doi: 10.1016/j.contraception.2022.11.002
CDC reports
- Curtis KM, Tepper NK, Jatlaoui TC. US medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(RR-3):1–104.
- Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(No. RR-4):1–66.
Statements of support
Major medical professional organizations and patient advocates have called for oral contraception to be available without a prescription. View their statements below.
American Medical Association
American College of Obstetrics and Gynecology (ACOG)
American Academy of Family Physicians
North American Society for Pediatric and Adolescent Gynecology
American College of Clinical Pharmacy
Oral Contraceptives OTC Working Group
Population Council
Advocates for Youth
Planned Parenthood
As seen in
Perrigo Press Release
FDA Joint Advisory Committee Votes in Favor of Perrigo's Opill® Daily Oral Contraceptive for OTC Use
A Birth Control Pill May Soon Be Available Over the Counter. Here’s What to Know
What To Know About Opill® —The Birth Control Pill FDA Advisors Support Making Available Over-The-Counter
FDA Panel Recommends the First Over-the-Counter Birth Control Pill
What Is Opill®? FDA Panel Votes in Favor of Over-the-Counter Birth Control
FDA advisers vote in favor of allowing 1st over-the-counter birth control pill
FDA votes unanimously for over-the-counter sale of birth control pill
FDA panel recommends allowing birth control pill to be sold over the counter
Advisers to the FDA back first over-the-counter birth control pill